Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study.
Rzany B, Bayerl C, Bodokh I, Boineau D, Dirschka T, Queille-Roussel C, Sebastian M, Sommer B, Poncet M, Guennoun M, Podda M. Rzany B, et al. Among authors: boineau d. J Cosmet Laser Ther. 2011 Jun;13(3):107-12. doi: 10.3109/14764172.2011.571699. J Cosmet Laser Ther. 2011. PMID: 21609212 Clinical Trial.
Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial.
Ascher B, Rzany B, Kestemont P, Hilton S, Heckmann M, Bodokh I, Noah EM, Boineau D, Kerscher M, Volteau M, Le Berre P, Picaut P. Ascher B, et al. Among authors: boineau d. Aesthet Surg J. 2020 Aug 14;40(9):1000-1008. doi: 10.1093/asj/sjz248. Aesthet Surg J. 2020. PMID: 31550352 Free PMC article. Clinical Trial.
Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial.
Ascher B, Kestemont P, Boineau D, Bodokh I, Stein A, Heckmann M, Dendorfer M, Pavicic T, Volteau M, Tse A, Picaut P, Rzany B. Ascher B, et al. Among authors: boineau d. Aesthet Surg J. 2018 Feb 17;38(2):183-191. doi: 10.1093/asj/sjw272. Aesthet Surg J. 2018. PMID: 28200002 Clinical Trial.
Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.
Ascher B, Rzany B, Kestemont P, Hilton S, Heckmann M, Bodokh I, Noah EM, Boineau D, Kerscher M, Volteau M, Le Berre P, Picaut P. Ascher B, et al. Among authors: boineau d. Aesthet Surg J. 2020 Jan 1;40(1):93-104. doi: 10.1093/asj/sjz003. Aesthet Surg J. 2020. PMID: 30893430 Free PMC article. Clinical Trial.
Fractionated bipolar radiofrequency and bipolar radiofrequency potentiated by infrared light for treating striae: A prospective randomized, comparative trial with objective evaluation.
Harmelin Y, Boineau D, Cardot-Leccia N, Fontas E, Bahadoran P, Becker AL, Montaudié H, Castela E, Perrin C, Lacour JP, Passeron T. Harmelin Y, et al. Among authors: boineau d. Lasers Surg Med. 2016 Mar;48(3):245-53. doi: 10.1002/lsm.22458. Epub 2016 Jan 12. Lasers Surg Med. 2016. PMID: 27020000 Clinical Trial.
Treatment of hidradenitis suppurativa using a long-pulsed hair removal neodymium:yttrium-aluminium-garnet laser: A multicenter, prospective, randomized, intraindividual, comparative trial.
Naouri M, Maruani A, Lagrange S, Cogrel O, Servy A, Collet Vilette AM, Fourcade S, Gral N, Perrillat Y, Rouaud RB, Cartier H, Maire C, Boineau D, Toubel G, Ollivier I, Le Pillouer-Prost A, Passeron T. Naouri M, et al. Among authors: boineau d. J Am Acad Dermatol. 2021 Jan;84(1):203-205. doi: 10.1016/j.jaad.2020.04.117. Epub 2020 Apr 26. J Am Acad Dermatol. 2021. PMID: 32348825 Clinical Trial. No abstract available.
25 results